Pieris Pharmaceuticals Free Cash Flow (Quarterly) Analysis

Pieris Pharmaceuticals Inc (PIRS)

15.95 -0.15 (-0.93%) USD | NASDAQ | Nov 14, 16:00

15.69 -0.26 (-1.63%) Pre-Market: 20:00

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
June 30, 2024	-1.48M
March 31, 2024	-6.996M
December 31, 2023	-19.66M
September 30, 2023	-9.792M
June 30, 2023	-13.50M
March 31, 2023	-11.04M
December 31, 2022	-12.92M
September 30, 2022	-8.812M
June 30, 2022	-16.21M
March 31, 2022	-23.03M
December 31, 2021	-11.29M
September 30, 2021	-14.83M
June 30, 2021	29.68M
March 31, 2021	-12.17M
December 31, 2020	-14.00M
September 30, 2020	-6.73M
June 30, 2020	-10.84M
March 31, 2020	-17.06M
December 31, 2019	-15.15M
September 30, 2019	-12.88M
June 30, 2019	-11.67M
March 31, 2019	-15.23M

Date	Value
December 31, 2018	-9.623M
September 30, 2018	-14.68M
June 30, 2018	-9.382M
March 31, 2018	30.92M
December 31, 2017	-5.513M
September 30, 2017	34.91M
June 30, 2017	-7.185M
March 31, 2017	25.59M
December 31, 2016	-6.966M
September 30, 2016	-3.774M
June 30, 2016	-6.167M
March 31, 2016	1.959M
December 31, 2015	-2.844M
September 30, 2015	-3.732M
June 30, 2015	-3.117M
March 31, 2015	-3.634M
September 30, 2014	-0.0139M
June 30, 2014	-0.0081M
March 31, 2014	-0.0003M
December 31, 2013	-0.0022M
September 30, 2013	-0.0045M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-23.03M

Minimum

Mar 2022

29.68M

Maximum

Jun 2021

-10.31M

Average

-12.17M

Median

Mar 2021

Free Cash Flow (Quarterly) Benchmarks